Crossmark

Medications on hypertension, hyperlipidemia, diabetes, and risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis

Published Online: 2022-05-26

Published Print: 2022-09

Authors

Hu, Nan https://orcid.org/0000-0002-4046-8439
Ji, Hongyan
License Information

Text and Data Mining valid from 2022-05-26

Version of Record valid from 2022-05-26
More Information

Article History

Received: 7 March 2022

Accepted: 11 May 2022

First Online: 26 May 2022

Declarations

:

: Ethical approval and consent to participate were not necessary for this systematic review.

: Not applicable.

: The authors declare no competing interests.

Document is current